TBK1 and cancer: Together with the decrease in LC3B-II after amlexanox treatment, our data indicate that TBK1 and IKKε are involved in the pro-survival effects of autophagy in cancer, which might be counteracted by the administration of IKKε/TBK1 inhibitors.